Ex vivo treatment of patient biopsies as a novel method to assess colorectal tumour response to the MEK1/2 inhibitor, Selumetinib
about
Ex vivo treatment of patient biopsies as a novel method to assess colorectal tumour response to the MEK1/2 inhibitor, Selumetinib
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Ex vivo treatment of patient b ...... MEK1/2 inhibitor, Selumetinib
@en
type
label
Ex vivo treatment of patient b ...... MEK1/2 inhibitor, Selumetinib
@en
prefLabel
Ex vivo treatment of patient b ...... MEK1/2 inhibitor, Selumetinib
@en
P2093
P2860
P1433
P1476
Ex vivo treatment of patient b ...... MEK1/2 inhibitor, Selumetinib
@en
P2093
Lesley A Stark
Sonia M Novo
Stephen R Wedge
P2860
P2888
P356
10.1038/S41598-017-12222-9
P407
P577
2017-09-20T00:00:00Z